Mangalam Drugs & Organics Limited (BOM:532637)
India
· Delayed Price · Currency is INR 33.17
-0.81 (-2.38%)
At close: Mar 10, 2026
Mangalam Drugs & Organics Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Net Income | - | 67.21 | -90.72 | 12.7 | 196.58 | 279.71 | Upgrade
|
| Depreciation & Amortization | - | 155.16 | 65.72 | 104.36 | 97.78 | 86.31 | Upgrade
|
| Other Amortization | - | 10.91 | 9.2 | 5.53 | 4.71 | 5.44 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0.74 | 0.7 | 0.03 | 1.74 | 0.3 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | 0.12 | - | Upgrade
|
| Other Operating Activities | - | 120.46 | 193.32 | 138.97 | 112.05 | 103.13 | Upgrade
|
| Change in Accounts Receivable | - | -111.28 | 10.47 | -0.43 | 78.22 | -136.08 | Upgrade
|
| Change in Inventory | - | -151.62 | 168.88 | -203.61 | -585.18 | 62.55 | Upgrade
|
| Change in Accounts Payable | - | 249.86 | -199.04 | 425.26 | 111.52 | -139.15 | Upgrade
|
| Change in Other Net Operating Assets | - | 85.99 | -119.41 | -87.58 | 239.55 | 13.29 | Upgrade
|
| Operating Cash Flow | - | 425.94 | 39.13 | 395.23 | 257.09 | 275.5 | Upgrade
|
| Operating Cash Flow Growth | - | 988.64% | -90.10% | 53.73% | -6.68% | -9.81% | Upgrade
|
| Capital Expenditures | - | -202.01 | -118.33 | -279.14 | -276.69 | -314.36 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 7.28 | 0.05 | 57.41 | 1.36 | 1.51 | Upgrade
|
| Investment in Securities | - | - | -0 | - | 2.07 | - | Upgrade
|
| Other Investing Activities | - | 0 | 0 | 0.01 | 0.01 | - | Upgrade
|
| Investing Cash Flow | - | -194.72 | -118.27 | -221.72 | -273.26 | -312.85 | Upgrade
|
| Short-Term Debt Issued | - | - | 169.4 | 24.71 | - | 93.21 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 182.27 | 27.04 | Upgrade
|
| Total Debt Issued | - | - | 169.4 | 24.71 | 182.27 | 120.24 | Upgrade
|
| Short-Term Debt Repaid | - | -26.59 | - | - | -40.85 | - | Upgrade
|
| Long-Term Debt Repaid | - | -41.21 | -44.53 | -63.37 | - | - | Upgrade
|
| Total Debt Repaid | - | -67.8 | -44.53 | -63.37 | -40.85 | - | Upgrade
|
| Net Debt Issued (Repaid) | - | -67.8 | 124.87 | -38.66 | 141.41 | 120.24 | Upgrade
|
| Other Financing Activities | - | -149.33 | -72.6 | -127.51 | -111.62 | -93.26 | Upgrade
|
| Financing Cash Flow | - | -217.12 | 52.27 | -166.17 | 29.79 | 26.98 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | 0 | - | - | Upgrade
|
| Net Cash Flow | - | 14.09 | -26.88 | 7.34 | 13.63 | -10.37 | Upgrade
|
| Free Cash Flow | - | 223.93 | -79.2 | 116.09 | -19.6 | -38.86 | Upgrade
|
| Free Cash Flow Margin | - | 7.05% | -2.16% | 3.14% | -0.43% | -1.02% | Upgrade
|
| Free Cash Flow Per Share | - | 14.15 | -5.00 | 7.33 | -1.24 | -2.46 | Upgrade
|
| Cash Interest Paid | - | 149.33 | 72.6 | 127.51 | 111.62 | 93.26 | Upgrade
|
| Cash Income Tax Paid | - | 0.83 | 0.92 | -0.26 | 88.08 | 92.68 | Upgrade
|
| Levered Free Cash Flow | - | 116.22 | -67.72 | -43.82 | -243.32 | -272.24 | Upgrade
|
| Unlevered Free Cash Flow | - | 186.1 | -2.67 | 11.93 | -198.3 | -232.74 | Upgrade
|
| Change in Working Capital | - | 72.95 | -139.11 | 133.64 | -155.88 | -199.39 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.